SEC Form 4 · accession 0001645627-15-000007
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 14, 2015
Accepted (ET)
Dec 11, 2015 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 14, 2015 | P | 1,000 | $0.10 | A | 19,614,901 | D | |
| Common Stock | Oct 15, 2015 | P | 1,000 | $0.09 | A | 19,616,901 | D | |
| Common Stock | Oct 16, 2015 | P | 200 | $0.08 | A | 19,617,101 | D | |
| Common Stock | Oct 19, 2015 | P | 200 | $0.08 | A | 19,617,301 | D | |
| Common Stock | Oct 22, 2015 | P | 200 | $0.08 | A | 19,617,501 | D | |
| Common Stock | Oct 23, 2015 | P | 500 | $0.08 | A | 19,618,001 | D | |
| Common Stock | Oct 26, 2015 | P | 200 | $0.08 | A | 19,618,201 | D | |
| Common Stock | Oct 27, 2015 | P | 500 | $0.08 | A | 19,618,701 | D |
Table II — derivative securities
No Table II lines on this filing.